Noticias

Switching from a protease inhibitor-based regimen to a dolutegravir-based regimen: a randomized clinical trial to determine the effect on peripheral blood and ileum biopsies from ART-suppressed HIV-infected individuals

3 Junio, 2019

Dra. Carmen Hidalgo. FEA de la UGC de Enfermedades Infecciosas. Hospital Universitario Virgen de las Nieves, Granada.

Accesos directos